Table 3. Outcome/Survival.
Simultaneous | Staged | p-value | |
---|---|---|---|
Survival | |||
Overall median | 47 months | 48 months | |
Overall 12 months | 90.5% | 92.6% | |
Overall 60 months | 38.5% | 38.9% | 0.52 |
DFS 12 months | 51.5% | 72.5% | |
DFS 60 months | 25.3% | 24.3% | 0.09 |
Site of initial recurrence | |||
Patients | 269 | 89 | |
Liver | 134 (49.8%) | 38 (42.7%) | |
Lung | 68 (25.3%) | 24 (27.0%) | |
Lung and liver | 23 (8.6%) | 8 (9.0%) | |
Peritoneal/intestine | 35 (13.0%) | 15 (16.8%) | |
Other | 9 (3.3%) | 4 (4.5%) | 0.79 |
DFS, disease-free survival.